# DESCRIPTION

## FIELD OF THE INVENTION

- define invention scope

## BACKGROUND OF THE INVENTION

- describe inflammatory bowel diseases
- motivate HMGB1 inhibition

## SUMMARY OF THE INVENTION

- summarize invention

## DETAILED DESCRIPTION OF THE INVENTION

- define method of treating disease
- describe beads coated with HMGB1-binding agents
- specify administration methods for beads
- detail characteristics of beads and coatings
- describe agents that bind HMGB1
- specify preferred nucleic acid sequences
- outline attachment of agents to beads

### EXPERIMENTAL DETAILS

- introduce DNA-conjugated beads for HMGB1 removal
- describe materials used
- detail cell culture methods
- generate DNA-beads
- measure binding ratio of HMGB1 to DNA beads
- prepare FAM-labeled B2 DNA
- stain DNA beads with ethidium bromide
- conduct binding studies of DNA beads with HMGB1
- prepare HMGB1 protein and neutralize LPS
- measure cytokine levels
- measure HMGB1 levels
- conduct surface plasmon resonance analysis
- perform depletion and saturation studies
- analyze time course of DNA-beads and HMGB1 binding
- conduct stability study
- describe histology experiment
- detail quantitative PCR analysis
- outline statistical analysis
- introduce DNA conjugated beads generation
- demonstrate DNA-beads binding to HMGB1
- determine binding ratio of HMGB1 to DNA beads
- examine time kinetics of binding between beads and HMGB1
- analyze suppressive effects of DNA oligos on HMGB1-induced TNF release
- test cytotoxicity of DNA beads
- evaluate binding specificity of DNA beads to HMGB1
- examine binding of DNA beads to HMGB1 in presence of heparin
- examine binding of DNA beads to HMGB1 in presence of plasma
- examine binding of DNA beads to HMGB1 in presence of acid
- remove HMGB1 from RAW 264.7 cell supernatant stimulated with LPS
- remove HMGB1 from mouse sepsis serum
- remove HMGB1 from intestinal tissue and from stool of DSS induced colitis in mice
- evaluate stability of DNA-coated beads in biological fluid and temperature
- administer neutralizing anti-HMGB1 antibodies to ameliorate DSS-induced colon injury and inflammation in mice
- administer B2 beads to ameliorate colitis-induced inflammation in both IL-10 KO and DSS-induced colitis in mice
- discuss advantages of DNA-based HMGB1 sequester therapy in IBD
- describe synthesis of oligonucleotides
- describe structure of DNA linker

